Rapid and ultrasensitive detection of SARS-CoV-2 spike protein based on upconversion luminescence biosensor for COVID-19 point-of-care diagnostics

被引:12
|
作者
Li, Lihua [1 ]
Song, Menglin [1 ]
Lao, Xinyue [1 ]
Pang, Sin-Yi [1 ]
Liu, Yuan [1 ]
Wong, Man-Chung [1 ]
Ma, Yingjin [1 ]
Yang, Mo [2 ]
Hao, Jianhua [1 ]
机构
[1] Hong Kong Polytech Univ, Dept Appl Phys, Kowloon, Hong Kong, Peoples R China
[2] Hong Kong Polytech Univ, Dept Biomed Engn, Kowloon, Hong Kong, Peoples R China
关键词
Upconversion nanoparticles; Au nanorods; COVID-19 point-of-care diagnostics; FRET effect; SARS-CoV-2 spike protein; GOLD NANORODS; NANOPARTICLES; SIZE; NANOPROBES; SURFACE; DNA;
D O I
10.1016/j.matdes.2022.111263
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
Here, we firstly introduce a detection system consisting of upconversion nanoparticles (UCNPs) and Au nanorods (AuNRs) for an ultrasensitive, rapid, quantitative and on-site detection of SARS-CoV-2 spike (S) protein based on Forster resonance energy transfer (FRET) effect. Briefly, the UCNPs capture the S pro-tein of lysed SARS-CoV-2 in the swabs and subsequently they are bound with the anti-S antibodies mod-ified AuNRs, resulting in significant nonradiative transitions from UCNPs (donors) to AuNRs (acceptors) at 480 nm and 800 nm, respectively. Notably, the specific recognition and quantitation of S protein can be realized in minutes at 800 nm because of the low autofluorescence and high Yb-Tm energy transfer in upconversion process. Inspiringly, the limit of detection (LOD) of the S protein can reach down to 1.06 fg mL-1, while the recognition of nucleocapsid protein is also comparable with a commercial test kit in a shorter time (only 5 min). The established strategy is technically superior to those reported point-of-care biosensors in terms of detection time, cost, and sensitivity, which paves a new avenue for future on-site rapid viral screening and point-of-care diagnostics.(c) 2022 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Routine molecular point-of-care testing for SARS-CoV-2 reduces hospital-acquired COVID-19
    Livingstone, Robert
    Lin, Hlaing
    Brendish, Nathan J.
    Poole, Stephen
    Tanner, Alex R.
    Borca, Florina
    Smith, Trevor
    Stammers, Matthew
    Clark, Tristan W.
    [J]. JOURNAL OF INFECTION, 2022, 84 (04) : 558 - 565
  • [42] Gold Nanorod Assisted Enhanced Plasmonic Detection Scheme of COVID-19 SARS-CoV-2 Spike Protein
    Das, Chandreyee Manas
    Guo, Yan
    Yang, Guang
    Kang, Lixing
    Xu, Gaixia
    Ho, Ho-Pui
    Yong, Ken-Tye
    [J]. ADVANCED THEORY AND SIMULATIONS, 2020, 3 (11)
  • [43] Molecular and Serological Tests for COVID-19. A Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics
    Kubina, Robert
    Dziedzic, Arkadiusz
    [J]. DIAGNOSTICS, 2020, 10 (06)
  • [44] Development and performance of a point-of-care rapid antigen test for detection of SARS-COV-2 variants
    Liu, Lihong
    Meyers, Kathrine
    Purpura, Lawrence J.
    Nguyen, Nadia
    Mohri, Hiroshi
    Chang, Jennifer Y.
    Annavajhala, Medini K.
    Lopez, Leo, III
    Lee, Sang Won
    Shah, Jayesh
    Lane, Benjamin
    Cantos, Anyelina
    Tukuru, Sade A.
    Guo, Yicheng
    Ford, Kenra
    Chiu, Yueh-Ting
    Sheng, Zizhang
    Choesang, Tenzin
    Castor, Delivette
    Wang, Maple
    Pili, Christina
    Van Hoy, Michael N.
    Wallach, Andrew
    Horton, Jamie
    Chen, Zhiqiang
    Rosenthal, Susan
    McLaren, Son
    Jiang, Baowei
    Wang, Frank
    Lu, Helen H.
    Uhlemann, Anne-Catrin
    Ho, David D.
    Yin, Michael T.
    [J]. JOURNAL OF CLINICAL VIROLOGY PLUS, 2022, 2 (03):
  • [45] Clinical and operational impact of rapid point-of-care SARS-CoV-2 detection in an emergency department
    Gerlier, Camille
    Pilmis, Benoit
    Ganansia, Olivier
    Le Monnier, Alban
    Van, Jean-Claude Nguyen
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2021, 50 : 713 - 718
  • [46] Dimerization of SARS-CoV-2 nucleocapsid protein affects sensitivity of ELISA based diagnostics of COVID-19
    Khan, Wajihul Hasan
    Khan, Nida
    Mishra, Avinash
    Gupta, Surbhi
    Bansode, Vikrant
    Mehta, Deepa
    Bhambure, Rahul
    Ansari, M. Ahmad
    Das, Shukla
    Rathore, Anurag S.
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2022, 200 : 428 - 437
  • [47] Rapid Point-of-Care Assay by SERS Detection of SARS-CoV-2 Virus and Its Variants
    Guan, Peng-Cheng
    Zhang, Hong
    Li, Zhi-Yong
    Xu, Shan-Shan
    Sun, Miao
    Tian, Xian-Min
    Lin, Jia-Sheng
    Wen, Huan
    Zhang, Fan-Li
    Zhang, Yue-Jiao
    Ma, Zhan
    Yu, Guang-Jun
    Yang, Chaoyong
    Wang, Zhan-Xiang
    Song, Yanling
    Li, Jian-Feng
    Gu, Man-Man
    [J]. ANALYTICAL CHEMISTRY, 2022, 94 (51) : 17795 - 17802
  • [48] Point-of-Care Platform for Rapid Multiplexed Detection of SARS-CoV-2 Variants and Respiratory Pathogens
    Trick, Alexander Y.
    Chen, Fan-En
    Chen, Liben
    Lee, Pei-Wei
    Hasnain, Alexander C.
    Mostafa, Heba H.
    Carroll, Karen C.
    Wang, Tza-Huei
    [J]. ADVANCED MATERIALS TECHNOLOGIES, 2022, 7 (06)
  • [49] Merging microfluidics with luminescence immunoassays for urgent point-of-care diagnostics of COVID-19
    Yuan, Huijuan
    Chen, Peng
    Wan, Chao
    Li, Yiwei
    Liu, Bi-Feng
    [J]. TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2022, 157
  • [50] Chasing COVID-19 through SARS-CoV-2 spike glycoprotein
    Shailendra K. Saxena
    Swatantra Kumar
    Preeti Baxi
    Nishant Srivastava
    Bipin Puri
    R. K. Ratho
    [J]. VirusDisease, 2020, 31 (4) : 399 - 407